Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials.

Date publication

juin 2024

Journal

EClinicalMedicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Vuyyuru SK, Ma C, Nguyen TM, Zou G, Peyrin-Biroulet L, Danese S, Dulai P, Narula N, Singh S, Jairath V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38726222

Résumé

Disease extent in Ulcerative Colitis (UC) has prognostic implications for disease course. It is unclear whether the efficacy of medical therapies for moderate to severely active UC vary according to disease extent at enrollment.

Mots clés

Biologics, Distribution, Extent

Référence

EClinicalMedicine. 2024 06;72:102621